当前位置:首页 - 行情中心 - 翔宇医疗(688626) - 财务分析 - 现金流量表

翔宇医疗

(688626)

  

流通市值:92.96亿  总市值:92.96亿
流通股本:1.60亿   总股本:1.60亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金195,165,280.42941,559,024.65645,583,603.09437,110,263.39
  收到的税费返还3,500,993.1517,674,654.4812,966,123.457,897,672.48
  收到其他与经营活动有关的现金8,506,060.5466,629,874.9134,831,988.8924,952,835.37
  经营活动现金流入小计207,172,334.111,025,863,554.04693,381,715.43469,960,771.24
  购买商品、接受劳务支付的现金61,411,784.56272,586,969.7213,499,494.6142,961,167.18
  支付给职工以及为职工支付的现金69,991,849.39305,448,020.96241,620,921.61161,584,128.3
  支付的各项税费16,022,223.8764,824,266.651,986,550.7131,695,124.55
  支付其他与经营活动有关的现金35,883,750.59193,187,517.22115,077,243.9380,524,005.71
  经营活动现金流出小计183,309,608.41836,046,774.48622,184,210.85416,764,425.74
  经营活动产生的现金流量净额23,862,725.7189,816,779.5671,197,504.5853,196,345.5
二、投资活动产生的现金流量:
  收回投资收到的现金--5,150,7125,150,712
  取得投资收益收到的现金299,285.06923,882.89984,195.39931,405.6
  处置固定资产、无形资产和其他长期资产收回的现金净额-79,638.2726,252.9321,374.06
  处置子公司及其他营业单位收到的现金净额-5,150,712--
  收到的其他与投资活动有关的现金5,000,000180,000,000100,000,000-
  投资活动现金流入小计5,299,285.06186,154,233.16106,161,160.326,103,491.66
  购建固定资产、无形资产和其他长期资产支付的现金37,060,678.27287,183,038.88251,271,437.94192,917,997.24
  投资支付的现金10,000,0005,750,000--
  支付其他与投资活动有关的现金25,000,000289,509,726.01150,000,000100,000,000
  投资活动现金流出小计72,060,678.27582,442,764.89401,271,437.94292,917,997.24
  投资活动产生的现金流量净额-66,761,393.21-396,288,531.73-295,110,277.62-286,814,505.58
三、筹资活动产生的现金流量:
  吸收投资收到的现金--66,807,16017,849,160
  取得借款收到的现金164,852,156.62300,626,243.38263,693,438.9233,090,000
  收到其他与筹资活动有关的现金294,900,000507,587,160488,000,000411,000,000
  筹资活动现金流入小计459,752,156.62808,213,403.38818,500,598.9661,939,160
  偿还债务支付的现金10,000,000529,707,400298,990,000203,990,000
  分配股利、利润或偿付利息支付的现金2,208,760.7344,434,165.542,475,118.7240,915,441.23
  支付其他与筹资活动有关的现金348,500,00047,007,519.35221,896,833.49181,003,394.59
  筹资活动现金流出小计360,708,760.73621,149,084.85563,361,952.21425,908,835.82
  筹资活动产生的现金流量净额99,043,395.89187,064,318.53255,138,646.69236,030,324.18
四、汇率变动对现金及现金等价物的影响178,012.27-249,523.56-6,128.23-84,566.1
五、现金及现金等价物净增加额56,322,740.65-19,656,957.231,219,745.422,327,598
  加:期初现金及现金等价物余额683,255,595.23702,912,552.43702,912,552.43702,912,552.43
  期末现金及现金等价物余额739,578,335.88683,255,595.23734,132,297.85705,240,150.43
补充资料:
  净利润-75,986,946.04-33,482,193.16
  资产减值准备-8,064,545.2-2,353,330.71
  固定资产和投资性房地产折旧-43,966,500.38-21,285,691.33
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-43,966,500.38-21,285,691.33
  无形资产摊销-8,627,545.1-3,961,444.95
  长期待摊费用摊销-8,170,632.91-2,029,115.05
  处置固定资产、无形资产和其他长期资产的损失--26,252.93-21,374.06
  固定资产报废损失-178,374.86--
  公允价值变动损失--501,026--
  财务费用-5,886,655.58-3,846,168.64
  投资损失--5,939,079.55--6,082,117.6
  递延所得税--4,366,403.22-2,048,179.59
  其中:递延所得税资产减少--4,366,403.22-2,048,179.59
  存货的减少--74,267,559.48--26,806,380.69
  经营性应收项目的减少-5,130,536.48--8,894,867.75
  经营性应付项目的增加-95,810,648.89-24,122,208.94
  其他-16,581,049.95--
  现金的期末余额-683,255,595.23-705,240,150.43
  减:现金的期初余额-702,912,552.43-702,912,552.43
  现金及现金等价物的净增加额--19,656,957.2-2,327,598
公告日期2026-04-242026-04-242025-10-312025-08-29
审计意见(境内)标准无保留意见
TOP↑